BRKR
Get informed when a big investor buys or sells
+ FollowOvervalued by 85.3% based on the discounted cash flow analysis.
| Market cap | $9.35 Billion |
|---|---|
| Enterprise Value | $11.52 Billion |
| Dividend Yield | $0.20 (0.33%) |
| Earnings per Share | $-0.15 |
| Beta | 1.26 |
| Outstanding Shares | 152,200,000 |
| P/E Ratio | -87.83 |
|---|---|
| PEG | 11.2 |
| Price to Sales | 2.71 |
| Price to Book Ratio | 3.98 |
| Enterprise Value to Revenue | 3.29 |
| Enterprise Value to EBIT | 470.23 |
| Enterprise Value to Net Income | -162 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.98 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1234▼ 65.42% |
|---|---|
| Total Calls | 1,536,900▲ 609.23% |
| Total Puts | 189,600▲ 12.52% |
Holdings and activity of institutional investors.
| Ownership % | 94.39%▲ 4.42% |
|---|---|
| Total Invested | $8.60B▲ 73.99% |
| Investors Holding | 432▲ 79.00% |
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...